Protein repertoire impact of Ubiquitin-Proteasome System impairment: Insight into the protective role of beta-estradiol

Journal of Proteomics

Volumn 75, Issue 4, 2012, Pages 1440-1453

  D'Alessandro, Annamaria ^a,b   D'Aguanno, Simona ^a,b   Cencioni, Maria Teresa ^b   Pieroni, Luisa ^a,b   Diamantini, Adamo ^b   Battistini, Luca ^b   Longone, Patrizia ^b   Spalloni, Alida ^b   De Laurenzi, Vincenzo ^c   Bernardini, Sergio ^a   Federici, Giorgio ^a,d   Urbani, Andrea ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d Piazza Sant'Onofrio   (Vatican City State)

Author keywords

2 Dimensional Electrophoresis separation; Beta Estradiol; Meta analysis; Neurodegenerative Diseases; Shotgun Proteomics; Ubiquitin Proteasome System impairment

Indexed keywords

EPOXOMICIN; ESTRADIOL; PROTEASOME; UBIQUITIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; MOUSE; NEUROBLASTOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

AUTOPHAGY; BRAIN NEOPLASMS; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOSOMES; MASS SPECTROMETRY; MODELS, BIOLOGICAL; NEUROBLASTOMA; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOMICS; UBIQUITIN;

EID: 84855905275     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.11.014     Document Type: Article

References (57)

1. Jacinto E., Hall M.N. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 2003, 4:117-126.
2. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443:780-786.
3. Cuervo A.M. Autophagy: in sickness and in health. Trends Cell Biol 2004, 14:70-77.
4. Nedelsky N.B., Todd P.K., Taylor J.P. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim Biophys Acta 2008, 1782:691-699.
5. Pan T., Kondo S., Le W., Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008, 131:1969-1978.
6. Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 1998, 17:7151-7160.
7. McNaught K.S., Olanow C.W. Proteasome inhibitor-induced model of Parkinson's disease. Ann Neurol 2006, 60:243-247.
8. Rockwell P., Yuan H., Magnusson R., Figueiredo-Pereira M.E. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch Biochem Biophys 2000, 374:325-333.
9. D'Alessandro A., Pieroni L., Ronci M., D'Aguanno S., Federici G., Urbani A. Proteasome inhibitors therapeutic strategies for cancer. Recent Pat Anticancer Drug Discov 2009, 4:73-82.
10. McNaught K.S., Perl D.P., Brownell A.L., Olanow C.W. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 2004, 56:149-162.
11. McNaught K.S., Björklund L.M., Belizaire R., Isacson O., Jenner P., Olanow C.W. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 2002, 13:1437-1441.
12. Venezia V., Russo C., Repetto E., Nizzari M., Violani E., Carlo P., et al. Apoptotic cell death and amyloid precursor protein signaling in neuroblastoma SH-SY5Y cells. Ann N Y Acad Sci 2004, 1030:339-347.
13. Waters W.R., Harkins K.R., Wannemuehler M.J. Five-color flow cytometric analysis of swine lymphocytes for detection of proliferation, apoptosis, viability, and phenotype. Cytometry 2002, 48:146-152.
14. Kalejta R.F., Shenk T., Beavis A.J. Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry. Cytometry 1997, 29:286-291.
15. Cheung C.K., Mak Y.T., Swaminathan R. Automated trichloroacetic acid precipitation method for urine total protein. Ann Clin Biochem 1987, 24:140-144.
16. Görg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000, 21:1037-1053.
17. O'Farrell P.Z., Goodman H.M., O'Farrell P.H. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 1977, 12:1133-1141.
18. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
19. Vissers J.P., Langridge J.I., Aerts J.M. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics 2007, 6:755-766.
20. D'Aguanno S., D'Alessandro A., Pieroni L., Roveri A., Zaccarin M., Marzano V., et al. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation. J Proteome Res 2011, 4(10):416-428.
21. De Canio M., D'Aguanno S., Sacchetti C., Petrucci F., Cavagni G., Nuccetelli M., et al. Novel IgE recognized components of lolium perenne pollen extract: comparative proteomics evaluation of allergic patients sensitization profiles. J Proteome Res 2009, 8:4383-4391.
22. Li G.Z., Vissers J.P., Silva J.C., Golick D., Gorenstein M.V., Geromanos S.J. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009, 9:1696-1719.
23. Geromanos S.J., Vissers J.P., Silva J.C., Dorschel C.A., Li G.Z., Gorenstein M.V., et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics 2009, 9:1683-1695.
24. Silva J.C., Denny R., Dorschel C.A., Gorenstein M., Kass I.J., Li G.-Z., et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem 2005, 77:2187-2200.
25. Silva J.C., Denny R., Dorschel C.A., Gorenstein M.V., Li G.Z., Richardson K., et al. J. Mol Cell Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Proteomics 2006, 5:589-607.
26. Hughes M.A., Silva J.C., Geromanos S.J., Townsed C.A. Quantitative Downloaded from www.mcponline.org by on September 2, 2009, 35 proteomic analysis of drug-induced changes in mycobacteria. J Proteome Res 2006, 5:54-63.
27. Thomas P.D., Campbell M.J., Kejariwal A., Mi H., Karlak B., Daverman R., et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003, 13:2129-2141.
28. Mi H., Dong Q., Muruganujan A., Gaudet P., Lewis S., Thomas P.D. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res 2010, 38:D204-D210.
29. Spalloni A., Albo F., Ferrari F., Mercuri N., Bernardi G., Zona C., et al. Cu/Zn-superoxide dismutase (GLY93- > ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motorneurons in culture. Neurobiol Dis 2004, 15:340-350.
30. Silva J.C., Gorenstein M.V., Li G.-Z., Vissers J.P.C., Geromanos S.J. Absolute quantification of proteins by LCMSE. A virtue of parallel MS acquisition. Mol Cell Proteomics 2006, 5:144-156.
31. Díaz E., Pfeffer S.R. TIP47: a cargo selection device for mannose 6-phosphate receptor trafficking. Cell 1998, 93:433-443.
32. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy. Methods Mol Biol 2008, 445:227-244.
33. Morissette M., Al Sweidi S., Callier S., Di Paolo T. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 2008, 290:60-69.
34. Reed J.L., Dimayuga F.O., Davies L.M., Keller J.N., Bruce-Keller A.J. Estrogen increases proteasome activity in murine microglial cells. Neurosci Lett 2004, 367:60-65.
35. Hartz A.M., Madole E.K., Miller D.S., Bauer B. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. J Pharmacol Exp Ther 2010, 334:467-476.
36. Teoh H., Leung S.W., Man R.Y. Short-term exposure to physiological levels of 17 beta-estradiol enhances endothelium-independent relaxation in porcine coronary artery. Cardiovasc Res 1999, 42:224-231.
37. Li X., Li H., Li X.J. Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases. Brain Res Rev 2008, 59:245-252.
38. Soto C., Estrada L.D. Protein misfolding and neurodegeneration. Arch Neurol 2008, 65:184-189.
39. Yamamoto A., Simonsen A. The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration. Neurobiol Dis 2011, 43:17-28.
40. Caughey B., Lansbury P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003, 26:267-298.
41. Jellinger K.A. Formation and development of Lewy pathology: a critical update. J Neurol 2009, 256:270-279.
42. Ross C.A., Poirier M.A. Opinion: what is the role of protein aggregation in neurodegeneration?. Nat Rev Mol Cell Biol 2005, 6:891-898.
43. Spires-Jones T.L., Stoothoff W.H., de Calignon A., Jones P.B., Hyman B.T. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci 2009, 32:150-159.
44. Williams A.J., Paulson H.L. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci 2008, 31:521-528.
45. Lin X., Parisiadou L., Gu X.L., Wang L., Shim H., Sun L., et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 2009, 64:807-827.
46. Xia H., Mao Q., Eliason S.L., Harper S.Q., Martins I.H., Orr H.T., et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004, 10:816-820.
47. Yamamoto A., Lucas J.J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000, 101:57-66.
48. Alves-Rodrigues A., Gregori L., Figueiredo-Pereira M.E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 1998, 21:516-520.
49. Liscic R.M., Grinberg L.T., Zidar J., Gitcho M.A., Cairns N.J. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol 2008, 15:772-780.
50. Tan C.F., Eguchi H., Tagawa A., Onodera O., Iwasaki T., Tsujino A., et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosiswith or without SOD1 genemutation. Acta Neuropathol 2007, 113:535-542.
51. Brinton R.D., Tran J., Proffitt P., Montoya M. 17 ß-Estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 1997, 22:1339-1351.
52. Green P.S., Simpkins J.W. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann N Y Acad Sci 2000, 924:93-98.
53. Greenfield J.P., Leung L.W., Cai D., Kaasik K., Gross R.S., Rodriguez-Boulan E., et al. Estrogen lowers Alzheimer ß-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 2002, 277:12128-12136.
54. Regan R.F., Guo Y. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res 1997, 764:133-140.
55. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., et al. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 2006, 147:3076-3084.
56. Joly A.L., Wettstein G., Mignot G., Ghiringhelli F., Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010, 2:238-247.
57. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy. Methods Mol Biol 2008, 445:227-244.